Followers | 507 |
Posts | 10138 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Sunday, June 28, 2015 11:03:10 AM
bullish
## source: finance.yahoo.com
Fri, 26 Jun 2015 23:04:07 GMT ~ HTML PDF
[at noodls] - GEORGE TOWN, GRAND CAYMAN -- (Marketwired) -- 06/02/15 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ('Theravance Biopharma' or the 'Company') announced today that stock options to purchase an aggregate ...
read full: http://www.noodls.com/view/27B9EC8E05AFA214C736275DDCFC104CA2893262
*********************************************************
Fri, 05 Jun 2015 13:16:00 GMT ~ 5 Biotech Stocks Poised for Breakouts
read full: http://www.thestreet.com/story/13176437/1/5-biotech-stocks-poised-for-breakouts.html?puc=yahoo&cm_ven=YAHOO
*********************************************************
Tue, 02 Jun 2015 21:09:11 GMT ~ Theravance Biopharma Announces New Employment Inducement Awards
[at noodls] - GEORGE TOWN, GRAND CAYMAN -- (Marketwired) -- 06/02/15 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ('Theravance Biopharma' or the 'Company') announced today that stock options to purchase an aggregate ...
read full: http://www.noodls.com/view/152E7A1B96FBF4C57130F918FB5AB36C85A1A062
*********************************************************
Wed, 27 May 2015 12:29:08 GMT ~ Theravance Biopharma and SciClone Pharmaceuticals Enter Into Development and Commercialization Agreement for VIBATIV(R) (Telavancin) in China
[at noodls] - GEORGE TOWN, GRAND CAYMAN and FOSTER CITY, CA -- (Marketwired) -- 05/27/15 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ('Theravance Biopharma'), through an affiliate, and SciClone Pharmaceuticals (NASDAQ: ...
read full: http://www.noodls.com/view/D7C534DF2A1F08DCF33BFB704692586B17BD0DCC
*********************************************************
Wed, 27 May 2015 12:19:06 GMT ~ SciClone Pharmaceuticals and Theravance Biopharma Enter Into Development and Commercialization Agreement for VIBATIV(R) (Telavancin) in China
[at noodls] - FOSTER CITY, CA and GEORGE TOWN, GRAND CAYMAN -- (Marketwired) -- 05/27/15 -- SciClone Pharmaceuticals (NASDAQ: SCLN), ('SciClone'), a U.S.-based, China-focused specialty pharmaceutical company, and Theravance ...
read full: http://www.noodls.com/view/639BEFAFB1ED0E4FE9B4097F361D422957200C8D
*********************************************************
$THRX charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$THRX company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/THRX/company-info
Ticker: $THRX
OTC Market Place: Not Available
CIK code: 0001080014
Company name: Theravance, Inc.
Company website: http://www.theravance.com
Incorporated In: DE, USA
$THRX share structure
## source: otcmarkets.com
Market Value: $2,263,824,838 a/o Jun 26, 2015
Shares Outstanding: 116,872,733 a/o Apr 30, 2015
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.01
$THRX extra dd links
Company name: Theravance, Inc.
Company website: http://www.theravance.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/THRX/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/THRX/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=THRX+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=THRX+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=THRX+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/THRX/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/THRX/news - http://finance.yahoo.com/q/h?s=THRX+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/THRX/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/THRX/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/THRX/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/THRX/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/THRX/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/THRX/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/THRX/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/THRX/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=THRX+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/THRX
DTCC (dtcc.com): http://search2.dtcc.com/?q=Theravance%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Theravance%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Theravance%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.theravance.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.theravance.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.theravance.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/THRX/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/THRX
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/THRX/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/THRX/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/THRX/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001080014&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/THRX/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/THRX/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/THRX/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/THRX/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=THRX&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=THRX
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/THRX/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=THRX+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=THRX+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=THRX
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=THRX
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=THRX+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/THRX/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=THRX+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/THRX.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=THRX
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/THRX/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/THRX/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/THRX/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/THRX/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/THRX
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/THRX
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/THRX:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=THRX
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=THRX
$THRX DD Notes ~ http://www.ddnotesmaker.com/THRX
Recent THRX News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 02/26/2024 02:00:55 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/16/2024 05:15:06 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 09:00:26 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 02/14/2024 07:26:12 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 02/14/2024 07:22:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 03:44:05 PM
- Form SC TO-T/A - Tender offer statement by Third Party: [Amend] • Edgar (US Regulatory) • 02/14/2024 03:35:19 PM
- Theseus Pharmaceuticals Announces Closing of Tender Offer • PR Newswire (US) • 02/14/2024 01:30:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 05:36:57 PM
- Form SC 14D9/A - Solicitation, recommendation statements: [Amend] • Edgar (US Regulatory) • 02/07/2024 10:21:30 PM
- Form SC TO-T/A - Tender offer statement by Third Party: [Amend] • Edgar (US Regulatory) • 02/07/2024 10:15:51 PM
- Form SC 14D9/A - Solicitation, recommendation statements: [Amend] • Edgar (US Regulatory) • 01/30/2024 01:52:31 PM
- Form SC TO-T/A - Tender offer statement by Third Party: [Amend] • Edgar (US Regulatory) • 01/30/2024 01:23:43 PM
- Concentra Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Theseus Pharmaceuticals • Business Wire • 01/30/2024 01:00:00 PM
- Form SC 14D9 - Solicitation, recommendation statements • Edgar (US Regulatory) • 01/10/2024 02:47:20 PM
- Form SC TO-T - Tender offer statement by Third Party • Edgar (US Regulatory) • 01/10/2024 01:51:27 PM
- Form SC14D9C - Written communication relating to third party tender offer • Edgar (US Regulatory) • 12/22/2023 11:52:56 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/22/2023 11:36:08 AM
- Theseus Pharmaceuticals Enters into Agreement to Be Acquired by Concentra Biosciences for between $3.90 and $4.05 in Cash per Share Plus a Contingent Value Right • PR Newswire (US) • 12/22/2023 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2023 11:30:30 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/27/2023 11:37:46 AM
- Theseus Pharmaceuticals Confirms Receipt of Unsolicited Expression of Interest from Foresite Capital, LLC and OrbiMed Advisors LLC and Unsolicited Proposal from Concentra Biosciences LLC • PR Newswire (US) • 11/27/2023 11:30:00 AM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 11/24/2023 09:23:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/17/2023 09:01:52 PM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM